Nonfatal diseases and quality of life
perspectives in Brazil
Downloads
References
GBD 2013 DALYs and HALE Collaborators, Murray CJ, Barber RM, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145-91. PMID: 26321261; doi: 10.1016/S0140-6736(15)61340-X.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-59. PMID: 28919117; doi: 10.1016/S0140-6736(17)32154-2.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-1858. PMID: 30496104; doi: 10.1016/S0140-6736(18)32279-7.
Soelberg CD, Brown RE Jr, Du Vivier D, Meyer JE, Ramachandran BK. The US Opioid Crisis: Current Federal and State Legal Issues. Anesth Analg. 2017;125(5):1675-81. PMID: 29049113; doi: 10.1213/ANE.0000000000002403.
Stoicea N, Costa A, Periel L, et al. Current perspectives on the opioid crisis in the US healthcare system: A comprehensive literature review. Medicine (Baltimore). 2019;98(20):e15425. PMID: 31096439; doi: 10.1097/MD.0000000000015425.
Science History Institute. Opioids’ Devastating Return. Available from: Available from: https://www.sciencehistory.org/distillations/opioids-devastating-return Accessed in 2020 (Jan 2).
Berridge V. Victorian opium eating: responses to opiate use in nineteenth-century England. Vic Stud. 1978;21(4):437-61. PMID: 11615197.
Bussone G, Grazzi L. Understanding the relationship between pain and emotion in idiopathic headaches. Neurol Sci. 2013;34 Suppl 1:S29-31. PMID: 23695041; doi: 10.1007/s10072-013-1362-4.
Lampl C, Thomas H, Tassorelli C, et al. Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain. 2016;17:59. PMID: 27245683; doi: 10.1186/s10194-016-0649-2.
Zarcone D, Corbetta S. Shared mechanisms of epilepsy, migraine, and affective disorders. Neurol Sci. 2017;38(Suppl 1):73-6. PMID: 28527083; doi: 10.1007/s10072-017-2902-0.
Saper JR, Da Silva AN. Medication overuse headache: history, features, prevention and management strategies. CNS Drugs. 2013;27:867-77. PMID: 23925669; doi: 10.1007/s40263-013-0081-y.
Chou R, Deyo R, Friedly J, et al. Nonpharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(7):493-505. PMID: 28192793; doi: 10.7326/M16-2459.
Staiger TO, Gaster B, Sullivan MD, Deyo RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine (Phila Pa 1976). 2003;28(22):2540-5. PMID: 14624092; doi: 10.1097/01.BRS.0000092372.73527.BA.
